drugset / Trial / NCT00540709
PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+Lispro
RandomizedParallel-groupOpen-labelTreatment
Summary
Whether a once-daily basal injection of insulin glargine with mealtime injections of insulin lispro achieves equivalent glycaemic control (HbA1c) to administration of insulin lispro by continuous subcutaneous insulin infusion in Type 1 diabetic patients.
Timeline
- Start
- 2002-11
- Primary completion
- 2003-09
- Completion
- 2003-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin glargine | Protein / enzyme biologic | — | — |